Free Trial

Seer Q1 2024 Earnings Report

Seer logo
$2.29 -0.02 (-0.87%)
As of 01/17/2025 04:00 PM Eastern

Seer EPS Results

Actual EPS
-$0.32
Consensus EPS
-$0.31
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

Seer Revenue Results

Actual Revenue
$3.07 million
Expected Revenue
$3.55 million
Beat/Miss
Missed by -$480.00 thousand
YoY Revenue Growth
N/A

Seer Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Conference Call Audio

Seer Earnings Headlines

Stop guessing when stocks will move (use this)
Ever wonder why most traders make trading so complicated? Charts everywhere… Indicators on top of indicators… Eyes glued to screens all day. Here's something wild I discovered after analyzing 10 years of market data… The best trading system might just be... a calendar. Sounds crazy… But stick with me for a minute... I noticed that the most popular stocks have specific dates when they love to move up. Not random dates. Not "sometimes" dates. But precise windows of time that repeat year after year... for an entire decade.
See More Seer Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Seer? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Seer and other key companies, straight to your email.

About Seer

Seer (NASDAQ:SEER), a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

View Seer Profile

More Earnings Resources from MarketBeat